Predatory Bacteria: A Potential Ally against Multidrug-Resistant Gram-Negative Pathogens

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Kadouri, Daniel E ^a   To, Kevin ^a   Shanks, Robert M Q ^b   Doi, Yohei ^b  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BDELLOVIBRIO BACTERIOVORUS; CONTROLLED STUDY; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MICAVIBRIO AERUGINOSAVORUS; MULTIDRUG RESISTANCE; NONHUMAN; PREDATION; PREDATOR; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; ALPHAPROTEOBACTERIA; ANTIBIOSIS; BDELLOVIBRIO; DISK DIFFUSION; MICROBIAL VIABILITY; PHYSIOLOGY; PSEUDOMONAS;

ANIMALIA; BDELLOVIBRIO; BDELLOVIBRIO BACTERIOVORUS; NEGIBACTERIA;

ACINETOBACTER BAUMANNII; ALPHAPROTEOBACTERIA; ANTIBIOSIS; BDELLOVIBRIO; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL VIABILITY; PSEUDOMONAS;

EID: 84877048448     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063397     Document Type: Article

References (23)

1. Kallen AJ, Srinivasan A, (2010) Current epidemiology of multidrug-resistant gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 31Suppl 1: S51-54.
2. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, et al. (2007) Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 122: 160-166.
3. Davidov Y, Huchon D, Koval SF, Jurkevitch E, (2006) A new alpha-proteobacterial clade of Bdellovibrio-like predators: implications for the mitochondrial endosymbiotic theory. Environ Microbiol 8: 2179-2188.
4. Davidov Y, Jurkevitch E, (2004) Diversity and evolution of Bdellovibrio-and-like organisms (BALOs), reclassification of Bacteriovorax starrii as Peredibacter starrii gen. nov., comb. nov., and description of the Bacteriovorax-Peredibacter clade as Bacteriovoracaceae fam. nov. Int J Syst Evol Microbiol 54: 1439-1452.
5. Rendulic S, Jagtap P, Rosinus A, Eppinger M, Baar C, et al. (2004) A predator unmasked: life cycle of Bdellovibrio bacteriovorus from a genomic perspective. Science 303: 689-692.
6. Stolp H, Starr MP, (1963) Bdellovibrio bacteriovorus gen. et sp. n., a Predatory, Ectoparasitic, and Bacteriolytic Microorganism. Antonie Van Leeuwenhoek 29: 217-248.
7. Sockett RE, (2009) Predatory lifestyle of Bdellovibrio bacteriovorus. Annu Rev Microbiol 63: 523-539.
8. Lambina VA, Afinogenova AV, Romai Penabad S, Konovalova SM, Pushkareva AP, (1982) Micavibrio admirandus gen. et sp. nov. Mikrobiologiia 51: 114-117.
9. Lambina VA, Afinogenova AV, Romay Penobad Z, Konovalova SM, Andreev LV, (1983) New species of exoparasitic bacteria of the genus Micavibrio infecting gram-positive bacteria. Mikrobiologiia 52: 777-780.
10. Wang Z, Kadouri DE, Wu M, (2011) Genomic insights into an obligate epibiotic bacterial predator: Micavibrio aeruginosavorus ARL-13. BMC Genomics 12: 453.
11. Dashiff A, Junka RA, Libera M, Kadouri DE, (2011) Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus. J Appl Microbiol 110: 431-444.
12. Kadouri D, O'Toole GA, (2005) Susceptibility of biofilms to Bdellovibrio bacteriovorus attack. Appl Environ Microbiol 71: 4044-4051.
13. Kadouri D, Venzon NC, O'Toole GA, (2007) Vulnerability of pathogenic biofilms to Micavibrio aeruginosavorus. Appl Environ Microbiol 73: 605-614.
14. Clinical and Laboratory Standards Institute (2012) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Wayne, PA.
15. Tian GB, Adams-Haduch JM, Bogdanovich T, Wang HN, Doi Y, (2011) PME-1, an extended-spectrum b-lactamase identified in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55: 2710-2713.
16. Doi Y, Paterson DL, Adams-Haduch JM, Sidjabat HE, O'Keefe A, et al. (2009) Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 b-lactamase. Antimicrob Agents Chemother 53: 3159-3161.
17. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, et al. (2012) Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 55: 224-231.
18. Jurkevitch E, Minz D, Ramati B, Barel G, (2000) Prey range characterization, ribotyping, and diversity of soil and rhizosphere Bdellovibrio spp. isolated on phytopathogenic bacteria. Appl Environ Microbiol 66: 2365-2371.
19. Rogosky AM, Moak PL, Emmert EA, (2006) Differential predation by Bdellovibrio bacteriovorus 109J. Curr Microbiol 52: 81-85.
20. Markelova NY, (2010) Predacious bacteria, Bdellovibrio with potential for biocontrol. Int J Hyg Environ Health 213: 428-431.
21. Dwidar M, Monnappa AK, Mitchell RJ, (2012) The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus. BMB Rep 45: 71-78.
22. Martin MO, (2002) Predatory prokaryotes: an emerging research opportunity. J Mol Microbiol Biotechnol 4: 467-477.
23. Sockett RE, Lambert C, (2004) Bdellovibrio as therapeutic agents: a predatory renaissance? Nat Rev Microbiol 2: 669-675.